The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Synergy with combination of AKT inhibitor (MK-2206) and paclitaxel in head and neck squamous cell carcinoma.
Omar Ahmed
No relevant relationships to disclose
Wen-Liang Kuo
No relevant relationships to disclose
Madhavi Nagilla
No relevant relationships to disclose
Jeannette S. Messer
No relevant relationships to disclose
David L. Boone
No relevant relationships to disclose
Marina Sharifi
No relevant relationships to disclose
Kay Macleod
No relevant relationships to disclose
Ezra E.W. Cohen
No relevant relationships to disclose